Skip to main content
    N

    NRC Health (NRC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $26.33
    -0.23 (-0.87%)

    Market Cap: $563.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NRC Health (NRC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    NRC Health (NRC) trades at 35.4x trailing earnings and 4.0x sales. Its P/E of 35.4x is above its 5-year median of 28.2x. Its forward P/E is 17.2x. The median P/E across 7 similar companies is 17.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 105.8% higher over the next year. Its free cash flow yield is 3.2%.

    MultipleValue
    P/E (trailing)35.4x
    Forward P/E17.2x
    Price to sales4.0x
    EV/EBITDA27.4x
    Price to FCF31.0x
    EV/FCF36.4x
    PEG1.3
    FCF yield3.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 6.6% above 33.2x and its P/S is 42.0% below 6.9x.

    MultipleCurrent5-year median10-year median
    P/E35.4x28.2x33.2x
    P/S4.0x5.2x6.9x
    P/BN/A14.7x16.4x
    Medians of month-end values through Oct 2026: 58 to 60 months (5-year) and 118 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 16.9x in 2024 to 52.3x in 2019.

    Year endPriceP/EP/SP/B
    2025$18.7737.2x3.1x29.3x
    2024$17.6416.9x2.9x13.2x
    2023$39.5631.6x6.5x19.8x
    2022$37.3029.4x6.1x12.8x
    2021$41.5228.2x7.1x12.5x
    2020$42.7529.5x8.1x17.1x
    2019$65.9452.3x12.9x51.6x
    2018$38.1433.5x7.9x51.0x
    2017$37.3046.6x7.8x10.6x
    2016$19.0028.8x4.3x5.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NRC

    What is NRC's forward P/E ratio?

    NRC Health has a forward P/E ratio of 17.2x.

    Is NRC stock overvalued?

    GNG's valuation label for NRC is Fairly valued. Its P/E of 35.4x compares with a median of 17.6x across 7 similar companies.

    What is NRC's price to sales ratio?

    NRC Health has a price to sales ratio of 4.0x.

    What is NRC Health's average P/E ratio over 5 years?

    NRC Health's median P/E over the last 5 years is 28.2x, from 60 month-end values through Oct 2026.

    What is NRC's PEG ratio?

    NRC Health has a PEG ratio of 1.3.